MedKoo Cat#: 591995 | Name: Hexetidine
Featured

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Hexetidine is a pyrimidine-derived antiseptic with broad-spectrum antimicrobial activity, primarily used in oral and mucosal antiseptic formulations. It exerts its effects by disrupting microbial cell walls and inhibiting metabolic pathways essential for bacterial and fungal survival. Hexetidine is especially effective against gram-positive bacteria and yeasts, making it a common active ingredient in mouthwashes and throat sprays.

Chemical Structure

Hexetidine
Hexetidine
CAS#141-94-6

Theoretical Analysis

MedKoo Cat#: 591995

Name: Hexetidine

CAS#: 141-94-6

Chemical Formula: C21H45N3

Exact Mass: 339.3613

Molecular Weight: 339.61

Elemental Analysis: C, 74.27; H, 13.36; N, 12.37

Price and Availability

Size Price Availability Quantity
25mg USD 250.00 2 Weeks
50mg USD 350.00 2 Weeks
100mg USD 550.00 2 Weeks
250g USD 950.00 2 Weeks
Bulk Inquiry
Buy Now
Add to Cart
Related CAS #
No Data
Synonym
Hexetidine; NSC 17764; NSC-17764; NSC17764
IUPAC/Chemical Name
5-Amino-1,3-bis(2-ethylhexyl)hexahydro-5-methylpyrimidine
InChi Key
DTOUUUZOYKYHEP-UHFFFAOYSA-N
InChi Code
InChI=1S/C21H45N3/c1-6-10-12-19(8-3)14-23-16-21(5,22)17-24(18-23)15-20(9-4)13-11-7-2/h19-20H,6-18,22H2,1-5H3
SMILES Code
CC1(N)CN(CC(CC)CCCC)CN(CC(CC)CCCC)C1
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.03.00
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 339.61 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Eshiobo I, Ehizomen E, Omosofe F, Onuora V. Buccal mucosal graft urethroplasty for proximal bulbar urethral stricture: A revisit of the surgical technique and analysis of eleven consecutive cases. Niger Med J. 2016 Sep-Oct;57(5):266-271. PubMed PMID: 27833245; PubMed Central PMCID: PMC5036297. 2: Wallace S, Nazroo J, Bécares L. Cumulative Effect of Racial Discrimination on the Mental Health of Ethnic Minorities in the United Kingdom. Am J Public Health. 2016 Jul;106(7):1294-300. doi: 10.2105/AJPH.2016.303121. Epub 2016 Apr 14. PubMed PMID: 27077347; PubMed Central PMCID: PMC4984732. 3: Price AJ, Travis RC, Appleby PN, Albanes D, Barricarte Gurrea A, Bjørge T, Bueno-de-Mesquita HB, Chen C, Donovan J, Gislefoss R, Goodman G, Gunter M, Hamdy FC, Johansson M, King IB, Kühn T, Männistö S, Martin RM, Meyer K, Neal DE, Neuhouser ML, Nygård O, Stattin P, Tell GS, Trichopoulou A, Tumino R, Ueland PM, Ulvik A, de Vogel S, Vollset SE, Weinstein SJ, Key TJ, Allen NE; Endogenous Hormones, Nutritional Biomarkers, and Prostate Cancer Collaborative Group. Circulating Folate and Vitamin B(12) and Risk of Prostate Cancer: A Collaborative Analysis of Individual Participant Data from Six Cohorts Including 6875 Cases and 8104 Controls. Eur Urol. 2016 Dec;70(6):941-951. doi: 10.1016/j.eururo.2016.03.029. Epub 2016 Apr 6. PubMed PMID: 27061263; PubMed Central PMCID: PMC5094800. 4: Deryabin PG, Galegov GA, Andronova VA, Botikov AG. Analysis of Antiviral Properties of Hexoral In Vitro against Some Viruses that Cause Acute Respiratory Infections and Herpes. Bull Exp Biol Med. 2016 Jan;160(3):353-6. doi: 10.1007/s10517-016-3169-9. Epub 2016 Jan 11. PubMed PMID: 26750930. 5: Uygun-Can B, Kadir T, Gumru B. Effect of oral antiseptic agents on phospholipase and proteinase enzymes of Candida albicans. Arch Oral Biol. 2016 Feb;62:20-7. doi: 10.1016/j.archoralbio.2015.11.006. Epub 2015 Nov 12. PubMed PMID: 26615573. 6: Aoun G, Saadeh M, Berberi A. Effectiveness of Hexetidine 0.1% Compared to Chlorhexidine Digluconate 0.12% in Eliminating Candida Albicans Colonizing Dentures: A Randomized Clinical In Vivo Study. J Int Oral Health. 2015 Aug;7(8):5-8. PubMed PMID: 26464531; PubMed Central PMCID: PMC4588790. 7: Aoun G, Nasseh I, Saadeh M, Cassia A, Berberi A. Effectiveness of Hexetidine 0.1% in Eliminating Candida albicans Colonizing Dentures: A Randomized Clinical In Vivo Study. J Int Oral Health. 2015;7(Suppl 1):1-4. PubMed PMID: 26225095; PubMed Central PMCID: PMC4516077. 8: Chevalier M, Sakarovitch C, Precheur I, Lamure J, Pouyssegur-Rougier V. Antiseptic mouthwashes could worsen xerostomia in patients taking polypharmacy. Acta Odontol Scand. 2015 May;73(4):267-73. doi: 10.3109/00016357.2014.923108. Epub 2015 Jan 20. PubMed PMID: 25601200. 9: Linke GR, Tarantino I, Bruderer T, Celeiro J, Warschkow R, Tarr PE, Müller-Stich BP, Zerz A. Transvaginal access for NOTES: a cohort study of microbiological colonization and contamination. Endoscopy. 2012 Jul;44(7):684-9. doi: 10.1055/s-0032-1309390. Epub 2012 Apr 23. PubMed PMID: 22528675. 10: Jolivot PA, Dunyach-Remy C, Roussey A, Jalabert A, Mallié M, Hansel-Esteller S. [Assessment of in vitro activity and stability of antifungal suspensions for mouthrinses: to a reappraisal of empiric practices?]. Pathol Biol (Paris). 2012 Dec;60(6):362-8. doi: 10.1016/j.patbio.2012.01.002. Epub 2012 Feb 22. French. PubMed PMID: 22361161. 11: Martin M, Winterfeld I, Kramme E, Ewert I, Sedemund-Adib B, Mattner F. [Outbreak of Burkholderia cepacia complex caused by contaminated alcohol-free mouthwash]. Anaesthesist. 2012 Jan;61(1):25-9. doi: 10.1007/s00101-011-1954-4. Epub 2012 Jan 25. German. PubMed PMID: 22273822. 12: Afennich F, Slot DE, Hossainian N, Van der Weijden GA. The effect of hexetidine mouthwash on the prevention of plaque and gingival inflammation: a systematic review. Int J Dent Hyg. 2011 Aug;9(3):182-90. doi: 10.1111/j.1601-5037.2010.00478.x. Epub 2010 Sep 6. Review. PubMed PMID: 21356020. 13: Frey Tirri B. Antimicrobial topical agents used in the vagina. Curr Probl Dermatol. 2011;40:36-47. doi: 10.1159/000321047. Epub 2011 Feb 10. Review. PubMed PMID: 21325838. 14: [Prevention of respiratory infection in patients following surgical intervention]. Vestn Otorinolaringol. 2011;(6):88-90. Russian. PubMed PMID: 22433703. 15: Van der Weijden GA, Ten Heggeler JM, Slot DE, Rosema NA, Van der Velden U. Parotid gland swelling following mouthrinse use. Int J Dent Hyg. 2010 Nov;8(4):276-9. doi: 10.1111/j.1601-5037.2009.00419.x. PubMed PMID: 20961383. 16: Versteeg PA, Rosema NA, Hoenderdos NL, Slot DE, Van der Weijden GA. The plaque inhibitory effect of a CPC mouthrinse in a 3-day plaque accumulation model - a cross-over study. Int J Dent Hyg. 2010 Nov;8(4):269-75. doi: 10.1111/j.1601-5037.2009.00421.x. PubMed PMID: 20961382. 17: Uckuyu A, Ozcimen EE, Sevinc FC, Zeyneloglu HB. Efficacy of vaginal misoprostol before hysteroscopy for cervical priming in patients who have undergone cesarean section and no vaginal deliveries. J Minim Invasive Gynecol. 2008 Jul-Aug;15(4):472-5. doi: 10.1016/j.jmig.2008.03.001. PubMed PMID: 18588848. 18: Kunel'skaia NL, Izotova GN, Luchsheva IuV, Voloshina IA, Artem'ev ME, Kudriavtseva IuS. [Combined local therapy in oropharyngeal diseases]. Vestn Otorinolaringol. 2008;(2):62-6. Russian. PubMed PMID: 18454082. 19: Panchenko VN, Nozhenko AA. [Efficacy of an antiseptic dialysis of purulent wounds in the dentofacial region with hyvalix]. Lik Sprava. 2007 Jul-Sep;(5-6):117-9. Russian. PubMed PMID: 18416174. 20: Luchikhin LA, Beliakova LV, Vasil'ev RA. [Stopangin in the treatment of pharyngeal inflammation]. Vestn Otorinolaringol. 2006;(4):53-6. Russian. PubMed PMID: 17152477.